AGEN — Agenus Inc · P/E 1.6, rev $68.3M

Agenus Inc (AGEN) is a biotechnology company listed on US.

Latest reported AGEN revenue for 2026-06-30 was $68.3M. Net income was $38.6M. AGEN currently screens at market cap $134.5M and trailing P/E 1.6.

Use this AGEN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AGEN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AGEN SEC filings page. Lician reads the product cache first so this HTML stays unique to Agenus Inc even when a live quote feed is slow.

Agenus Inc latest statements (FY2025)

Latest cached year on this hub. Full AGEN income, balance, and cash tables.

  • Revenue$114.2M
  • Net Income-$3.1M
  • Total Assets$226.8M
  • Total Debt$0
  • Free Cash Flow-$77.2M

AGEN recent filings